Gibinski Univ.Clin.Cnter of Silesian Med.Uni.Katowice,Outpat

Katowice 40-752

0 studies enrolling now · 1 studies all time

What they study most

Asthma

Studies at this site

• Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma — Completed